Skip to content

A retrospective clinical study of the impact of serum potassium concentration on survival and intradialytic blood pressure in dialysis patients

A retrospective clinical study of the impact of mean levels of predialysis serum potassium on survival and minimum systolic blood pressure during dialysis - Impact of mean levels of predialysis serum potassium on survival and minimum systolic blood pressure during dialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056789
Enrollment
500
Registered
2025-12-31
Start date
2025-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage kidney disease undergoing hemodialysis and online hemodiafiltration

Interventions

None listed

Sponsors

Social medical corporation Kawashimakai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients on maintenance hemodialysis or online hemodialysis as of July 1, 2017

Exclusion criteria

Exclusion criteria: 1 Use of dialyzers with beta2-microgloburln clearance below 70 mL/min 2 Missing data for covariates at study entry 3 Dialysis conditionssuch as dialysis method and membrane material between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 4 Blood purification methods other than hemodialysis and online hemodiafiltration 5 Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 6 Pregnant or lactating patients 7 Patients with mean pre-dialysis potassium concentration of less than 3.5mEq/L and more than 6.5mEq/L for three months

Design outcomes

Primary

MeasureTime frame
2-year all-cause mortality

Secondary

MeasureTime frame
Monthly average minimum systolic blood pressure during dialysis at baseline, 1 year, and 2 years

Countries

Japan

Contacts

Public ContactManabu Tashiro

Social medical corporation Kawashimakai Kawashima Hospital Department of Nephrology

m.tashiro@khg.or.jp088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026